Protection against α-Naphthylisothiocyanate-Induced Acute Cholestasis in Mice by a Novel Taurine Conjugate of Ursodeoxycholate (UR-906)
Open Access
- 1 January 1993
- journal article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 63 (1) , 125-127
- https://doi.org/10.1254/jjp.63.125
Abstract
We investigated the effects of tauroursodeoxycholate (UR-906) and ursodeoxycholic acid (UDCA) on alpha-naphthylisothiocyanate (ANIT)-induced cholestasis in mice. UR-906 and UDCA were given intravenously 2 hr prior to and 2 hr after ANIT (80 mg/kg, p.o.) treatment. The animals were sacrificed 48 hr after ANIT administration, and serum markers of liver injury were examined. UR-906 prevented significant elevations in total bilirubin, bile acids and LDH. Furthermore, this drug reduced significant elevations in ALP and LAP. UDCA also prevented significant elevations in total bilirubin and LAP. These results indicate that UR-906 as well as UDCA has a beneficial effect against ANIT-induced cholestasis in mice.Keywords
This publication has 5 references indexed in Scilit:
- Definitive therapy for primary biliary cirrhosis—Fact or fiction?Gastroenterology, 1988
- Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the ratAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1985
- Effect of ursodeoxycholate on the bile flow in the ratLife Sciences, 1982
- Studies on Alpha-naphthylisothiocyanate Induced CholestasisKanzo, 1978
- The problem of primary biliary cirrhosisThe American Journal of Medicine, 1962